Ambulatory Blood Pressure Monitoring (ABPM) as THE reference standard to confirm diagnosis of hypertension in adults: Recommendation of the 2015 U.S. Preventive Services Task Force (USPSTF)

References

• Ayala DE, Hermida RC. (2013). Ambulatory blood pressure monitoring for the early identification of hypertension in pregnancy. Chronobiol Int. 30:233–59
   PubMed Web of Science ®Google Scholar
• Ayala DE, Moyá A, Crespo JJ, et al. (2013). Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes. Chronobiol Int. 30:99–115
   PubMed Web of Science ®Google Scholar
• Crespo C, Fernández JR, Aboy M, Mojón A. (2013). Clinical application of a novel automatic algorithm for actigraphy-based activity and rest period identification to accurately determine awake and asleep ambulatory blood pressure parameters and cardiovascular risk. Chronobiol Int. 30:43–54
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2011). Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J Am Coll Cardiol. 58:1165–73
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2012). Sleep-time blood pressure and the prognostic value of isolated-office and masked hypertension. Am J Hypertens. 25:297–305
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Crespo JJ, et al. (2013a). Influence of age and hypertension treatment-time on ambulatory blood pressure in hypertensive patients. Chronobiol. Int. 30:176–91
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernández JR, Mojón A. (2013b). Sleep-time blood pressure: Prognostic value and relevance as a therapeutic target for cardiovascular risk reduction. Chronobiol Int. 30:68–86
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fontao MJ, et al. (2013c). Ambulatory blood pressure monitoring: Importance of sampling rate and duration–48 versus 24 hours–on the accurate assessment of cardiovascular risk. Chronobiol Int. 30:55–67
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2013d). Ambulatory blood pressure thresholds for diagnosis of hypertension in patients with and without type 2 diabetes based on cardiovascular outcomes. Chronobiol Int. 30:132–44
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2013e). Cardiovascular risk of essential hypertension: Influence of class, number, and treatment-time regimen of hypertension medications. Chronobiol Int. 30:315–27
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, et al. (2013f). Differences between men and women in ambulatory blood pressure thresholds for diagnosis of hypertension based on cardiovascular outcomes. Chronobiol Int. 30:233–59
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Smolensky M, et al. (2013g). Asleep-time blood pressure: Relevance to the proper definition of isolated-office and masked hypertension. Hypertension Res. 36:471–2
   PubMed Web of Science ®Google Scholar
• Hermida RC, Smolensky MH, Ayala DE, et al. (2013h). 2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals. Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM). Chronobiol Int. 30:355–410
   PubMed Web of Science ®Google Scholar
• Hermida RC, Smolensky MH, Ayala DE, et al. (2014). Abnormalities of ambulatory blood pressure 24h patterns and normalization by bedtime hypertension chronotherapy in chronic kidney disease. Nephrol Dialysis Transplant. 29:1160–7
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2015a). Sleep-time BP: Prognostic marker of type 2 diabetes and therapeutic target for prevention. Diabetologia. doi: 10.1007/s00125-015-3748-8. [Epub ahead of print]
   Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. (2015b). Sleep-time BP: Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial. Diabetologia. doi: 10.1007/s00125-015-3749-7. [Epub ahead of print]
   Google Scholar
• Mojón A, Ayala DE, Piñeiro L, et al. (2013). Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease. Chronobiol Int. 30:145–58
   PubMed Web of Science ®Google Scholar
• Piper MA, Evans CV, Burda BU, et al. (2015). Diagnosis and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: A systematic review for the U.S. Preventive Services Task Force. Ann Internal Med. 162:192–204
   PubMed Web of Science ®Google Scholar
• Ríos MT, Domínguez-Sardiña M, Ayala DE, et al. (2013). Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring. Chronobiol Int. 30:192–206
   PubMed Web of Science ®Google Scholar
• Sheridan S, Pignone M, Donahue K. (2003). Screening for high blood pressure: A review of the evidence for the U.S. Preventive Services Task Force. Am J Prev Med. 25:151–8
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Hermida RC, Ayala DE, Portaluppi F. (2015). Ingestion-time differences in medication effects: Rationale for hypertension chronotherapy to reduce cardiovascular risk and initial proof-of-concept evidence. Curr Pharm Design. 21:773–90
   PubMed Web of Science ®Google Scholar
• U.S. Preventive Services Task Force. (2007). Screening for high blood pressure: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 147:783–6
   PubMed Web of Science ®Google Scholar